Pancreatic ACE2 receptor expression, together with increased prevalence of insulin-
requiring hyperglycemia in patients with coronavirus disease 2019 (COVID-19), suggested …

From December 2019 SARS‐Cov‐2 has affected almost all countries in the world, causing a
pandemic emergency. Over 260 million confirmed infection and over 5.2 million deaths have …

Background and aims New data has emerged regarding higher risk of coronavirus disease
2019 (COVID-19), and its severity and complications in patients with type 2 diabetes mellitus …

The devastating global pandemic Coronavirus disease 2019 (COVID 19) isolated in China
in January 2020 is responsible for an outbreak of pneumonia and other multisystemic …

Background. The COVID‐19 pandemic has an impact on the incidence of type 1 diabetes
and frequency of diabetic ketoacidosis. However, the exact relationships are unclear. It is …

The world is currently grappling with a dual pandemic of diabetes and coronavirus disease
2019 (COVID-19). Several articles published in the recent issues of Diabetes, Obesity and …

Background: Diabetes, is known to have a bilateral relationship with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Precise mechanism of diabetes onset in …

Certain chronic comorbidities, including diabetes, are highly prevalent in people with
coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe …

COVID-19 is an acronym formed by ''CO''for corona,''VI''for virus, and ''D''for disease. The
''19''represents 2019—the year when the infection started. This new disease was unknown …

Introduction Previous studies have shown disruption of glycometabolic control and new
diabetes mellitus (DM) diagnosis among patients with COVID-19. It is still unclear how the …